This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mabuchi, H. Articles by Takeda, R. Search for Related Content PubMed PubMed Citation Articles by Mabuchi, H. Articles by Takeda, R.

Circulation, Vol 79, 225-232, Copyright © 1989 by American Heart Association

ARTICLES

Development of coronary heart disease in familial hypercholesterolemia

H Mabuchi, J Koizumi, M Shimizu and R Takeda
Department of Internal Medicine, Kanazawa University School of Medicine, Japan.

We studied the development of coronary artery disease in 10 homozygous and 692 heterozygous patients with familial hypercholesterolemia. Seventy-five (22%) male heterozygotes and 35 (10%) female heterozygotes were affected by myocardial infarction, which was first noted in men in the 3rd decade of life and in women in the 4th decade of life. Thirty- eight (70%) out of the deceased 54 heterozygous patients died of coronary heart disease. The mean age at death was significantly less in male heterozygotes (54 years) than in female heterozygotes (69 years). Five homozygous and 105 male and 56 female heterozygous patients received coronary angiographic evaluation. The regression equations between age (X) and coronary stenosis index (Y) obtained by assigning score (0 to 5) to each of 15 coronary artery segments were Y = 1.57X - 20.43 (r = 0.956, p less than 0.05) in the homozygotes, Y = 0.52X - 9.11 (r = 0.438, p less than 0.001) in the male heterozygotes, and Y = 0.47X - 12.54 (r = 0.343, p less than 0.01) in the female heterozygotes. From these data, we can assume that coronary artery stenosis detectable by angiography will occur after 17 and 25 years of age in male and female heterozygotes, respectively, and the treatment of heterozygotes with lipid-lowering drugs can be delayed until late adolescence.

This article has been cited by other articles:

				J. Rodenburg, M. N. Vissers, A. Wiegman, A. S. P. van Trotsenburg, A. van der Graaf, E. de Groot, F. A. Wijburg, J. J.P. Kastelein, and B. A. Hutten Statin Treatment in Children With Familial Hypercholesterolemia: The Younger, the Better Circulation, August 7, 2007; 116(6): 664 - 668. [Abstract] [Full Text] [PDF]

				H.J. Avis, M.N. Vissers, E.A. Stein, F.A. Wijburg, M.D. Trip, J.J.P. Kastelein, and B.A. Hutten A Systematic Review and Meta-Analysis of Statin Therapy in Children With Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1803 - 1810. [Abstract] [Full Text] [PDF]

				A. Nohara, M.-a. Kawashiri, T. Claudel, M. Mizuno, M. Tsuchida, M. Takata, S. Katsuda, K. Miwa, A. Inazu, F. Kuipers, et al. High Frequency of a Retinoid X Receptor {gamma} Gene Variant in Familial Combined Hyperlipidemia That Associates With Atherogenic Dyslipidemia Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 923 - 928. [Abstract] [Full Text] [PDF]

				M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review Am. J. Epidemiol., September 1, 2004; 160(5): 421 - 429. [Abstract] [Full Text] [PDF]

				A. Wiegman, B. A. Hutten, E. de Groot, J. Rodenburg, H. D. Bakker, H. R. Buller, E. J. G. Sijbrands, and J. J. P. Kastelein Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia: A Randomized Controlled Trial JAMA, July 21, 2004; 292(3): 331 - 337. [Abstract] [Full Text] [PDF]

				A. Pollak, A. Rokach, A. Blumenfeld, L. J Rosen, L. Resnik, and R. Dresner Pollak Association of oestrogen receptor alpha gene polymorphism with the angiographic extent of coronary artery disease Eur. Heart J., February 1, 2004; 25(3): 240 - 245. [Abstract] [Full Text] [PDF]

				H. Lu, T. Higashikata, A. Inazu, A. Nohara, W. Yu, M. Shimizu, and H. Mabuchi Association of Estrogen Receptor-{alpha} Gene Polymorphisms With Coronary Artery Disease in Patients With Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): 817 - 823. [Abstract] [Full Text] [PDF]

				A. S. Wierzbicki, M. Lambert-Hammill, P. J. Lumb, and M. A. Crook Renin-Angiotensin System Polymorphisms and Coronary Events in Familial Hypercholesterolemia Hypertension, November 1, 2000; 36(5): 808 - 812. [Abstract] [Full Text] [PDF]

				M. Kawasuji, N. Sakakibara, S. Fujii, T. Yasuda, and Y. Watanabe Coronary artery bypass surgery with arterial grafts in familial hypercholesterolemia J. Thorac. Cardiovasc. Surg., May 1, 2000; 119(5): 1008 - 1013. [Abstract] [Full Text] [PDF]

				J. P. O'Malley, J. P. BS, C. L. Maslen, and D. R. Illingworth Angiotensin-Converting Enzyme DD Genotype and Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia Circulation, May 19, 1998; 97(18): 1780 - 1783. [Abstract] [Full Text] [PDF]

				A. F. Vuorio, H. Turtola, K.-M. Piilahti, P. Repo, T. Kanninen, and K. Kontula Familial Hypercholesterolemia in the Finnish North Karelia : A Molecular, Clinical, and Genealogical Study Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3127 - 3138. [Abstract] [Full Text]

				L. K. Andersen, H. K. Jensen, S. Juul, and O. Faergeman Patients' Attitudes Toward Detection of Heterozygous Familial Hypercholesterolemia Arch Intern Med, March 10, 1997; 157(5): 553 - 560. [Abstract] [PDF]

				I. Yokoyama, T. Ohtake, S.-i. Momomura, J. Nishikawa, Y. Sasaki, and M. Omata Reduced Coronary Flow Reserve in Hypercholesterolemic Patients Without Overt Coronary Stenosis Circulation, December 15, 1996; 94(12): 3232 - 3238. [Abstract] [Full Text]

				K. Takata, K. Saku, T. Ohta, M. Takata, H. Bai, S. Jimi, R. Liu, H. Sato, G. Kajiyama, and K. Arakawa A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1866 - 1874. [Abstract] [Full Text]

				S. N. Pimstone, S. E. Gagne, C. Gagne, P. J. Lupien, D. Gaudet, R. R. Williams, M. Kotze, P. W. A. Reymer, J. C. Defesche, J. J. P. Kastelein, et al. Mutations in the Gene for Lipoprotein Lipase : A Cause for Low HDL Cholesterol Levels in Individuals Heterozygous for Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1704 - 1712. [Abstract] [Full Text]

				J. Ferrieres, J. Lambert, S. Lussier-Cacan, and J. Davignon Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation Circulation, August 1, 1995; 92(3): 290 - 295. [Abstract] [Full Text]

				M. Kawasuji, N. Sakakibara, H. Takemura, Y. Matsumoto, H. Mabuchi, and Y. Watanabe Coronary artery bypass grafting in familial hypercholesterolemia J. Thorac. Cardiovasc. Surg., February 1, 1995; 109(2): 364 - 369. [Abstract] [Full Text]

				Y. Kita, M. Shimizu, N. Sugihara, K. Shimizu, M. Miura, J. Koizumi, H. Mabuchi, and R. Takeda Abdominal Aortic Aneurysms in Familial Hypercholesterolemia--Case Reports Angiology, June 1, 1993; 44(6): 491 - 499. [Abstract] [PDF]

				M. W. Gillman Screening for Familial Hypercholesterolemia in Childhood Arch Pediatr Adolesc Med, April 1, 1993; 147(4): 393 - 396. [Abstract] [PDF]